Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
8 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Hillman Solns (NASDAQ: HLMN ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Hillman Solns reported a 10% increase in net sales to
U.S. stock futures pointed lower Monday after weekend comments from OpenAI and Anthropic executives revived concerns about the pace of AI development. Nvidia, Micron, Sandisk and Oracle were among the stocks cited as in focus.
Dow and S&P 500 futures edged higher while Nasdaq 100 futures slipped ahead of the August PPI report. The 10-year Treasury yield was 4.85% and the two-year yield was 4.43%; FedWatch put a 60.2% chance on a September rate hike.
U.S. stocks fell Tuesday as crude oil extended higher, pushing the 10-year Treasury yield above 4.8% and reviving bets the Federal Reserve could raise rates next week. The Dow led declines, while Amgen was the biggest drag.
Sportsman's Warehouse reported Q2 2026 net sales of $295.6 million, up 6%, with same-store sales flat. Hunting and shooting sports sales rose nearly 7% as the company cut inventory by more than $44 million year over year.
U.S. equities fell for a second straight session as Treasury yields climbed for a fifth day and crude oil extended gains, with markets increasingly pricing a Federal Reserve rate hike this month.
U.S. stock futures were mixed on Monday, as the Dow Jones index advanced, while the Nasdaq 100 and S&P 500 indices fell, following Friday’s higher close. Late Sunday, global markets turned cautious after the U.S. launched another round of strikes against Iran, fueling a rally in crude oil prices and weighing on U.S. st
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92% to $0.5. The market value of their outstanding shares is at $6.8 million. Advanced Biomed (NASDAQ